BCL2L1 and pancreatic neoplasm: BCL-XL-induced increase in the migratory and invasive potential was confirmed in pancreatic cancer cell lines, and a remodeling of the actin cytoskeleton was observed in both cell cultures and pancreatic cancer xenografts.